Vantis is a digital solution for chronic cardiovascular diseases that requires personalized ongoing treatment for decades.
Vantis has raised $10.9M in total funding. The most recent round was Series A. The last funding was announced in March 2025.
Vantis's investors include Firstminute Capital, Angelini Ventures, b2venture, Bayern Kapital, Twip Impact Ventures.
Vantis is headquartered in Munich, Germany.
Vantis is a digital solution for chronic cardiovascular diseases that requires personalized ongoing treatment for decades.
Vantis is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vantis — Funding & Investors." VCBacked, March 12, 2025, https://www.vcbacked.co/company/vantis. Accessed July 19, 2026.
VCBacked. (2025). Vantis — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/vantis
{{cite web |title=Vantis — Funding & Investors |url=https://www.vcbacked.co/company/vantis |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated